G. Stehle
Impact in
- Internal Medicine top 2%
- Venous Thromboembolism Diagnosis and Management
- Oncology top 5%
- Peptidase Inhibition and Analysis
- Cancer Cells and Metastasis
Papers in
-
- Venous Thromboembolism Diagnosis and Management 10
- Hematology 21
- Blood Coagulation and Thrombosis Mechanisms 10
- Chronic Myeloid Leukemia Treatments 6
- Co-authors
- D. L. HeeneG. HartungAndreas WunderW. Maier‐BorstHannsjörg SinnHartmut KuthanGerd MunzertJob Harenberg
In The Last Decade
G. Stehle
52 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 100
- Internal Medicine 205
- Oncology 698
- Hematology 258
- Biomaterials 296
- Radiology, Nuclear Medicine and Imaging 338
Countries citing papers authored by G. Stehle
This map shows the geographic impact of G. Stehle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Stehle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Stehle more than expected).
Fields of papers citing papers by G. Stehle
This network shows the impact of papers produced by G. Stehle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Stehle. The network helps show where G. Stehle may publish in the future.
Co-authorship network
The 25 scholars most cited alongside G. Stehle, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 39 | |
| 2 | 2014 | 38 | |
| 3 | 2003 | 179 | |
| 4 | 2003 | 52 | |
| 5 | 2003 | 289 | |
| 6 | 2001 | 54 | |
| 7 | 2000 | 3 | |
| 8 | 1999 | 15 | |
| 9 | 1998 | 29 | |
| 10 | 1997 | 59 | |
| 11 | 1997 | 250 | |
| 12 | 1997 | 5 | |
| 13 | 1995 | 5 | |
| 14 | Anti-factor Xa determination in blood: a new method for controlling heparin therapy. | 1993 | 3 |
| 15 | 1992 | 20 | |
| 16 | 1992 | 16 | |
| 17 | 1991 | 10 | |
| 18 | 1991 | 8 | |
| 19 | 1990 | 3 | |
| 20 | 1989 | 17 |
About G. Stehle
G. Stehle is a scholar working on Internal Medicine, Hematology, Cardiology and Cardiovascular Medicine, Oncology and Radiology, Nuclear Medicine and Imaging, having authored 53 papers that have together received 2.0k indexed citations. Recurring topics across this work include Blood Coagulation and Thrombosis Mechanisms (10 papers), Venous Thromboembolism Diagnosis and Management (10 papers), Radiopharmaceutical Chemistry and Applications (7 papers), Atrial Fibrillation Management and Outcomes (7 papers), Cancer Treatment and Pharmacology (6 papers), Chronic Myeloid Leukemia Treatments (6 papers), Heparin-Induced Thrombocytopenia and Thrombosis (5 papers) and Proteoglycans and glycosaminoglycans research (5 papers). The work is most often cited by research in Internal Medicine (205 citations), Oncology (698 citations), Hematology (258 citations), Biomaterials (296 citations) and Radiology, Nuclear Medicine and Imaging (338 citations). G. Stehle has collaborated with scholars based in Germany, Austria and Japan. Frequent co-authors include D. L. Heene, G. Hartung, Andreas Wunder, W. Maier‐Borst, Hannsjörg Sinn, Hartmut Kuthan, Gerd Munzert, Job Harenberg, Karl‐Heinz Heider and C.‐E. Dempfle. Their work appears in journals such as European Journal of Cancer, Anti-Cancer Drugs, Thrombosis Research, Thrombosis and Haemostasis and International Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.